Understanding surface acoustic wave atomisation for pulmonary delivery of drug aerosols in personalised medicine. Delivering drugs via the lung is hampered by development costs and inadequate technology. This project will provide an understanding of atomisation in our unique respire system, enabling not only the delivery of new vaccines and drugs but also the rapid and cost effective development of new disease treatments personalised to the patient.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0989341
Funder
Australian Research Council
Funding Amount
$690,000.00
Summary
Advanced NanoBiomaterials Imaging Facility. The convergence of nanotechnology with biotechnology offers unprecedented opportunities to prepare nanomaterials with defined structure and function on the nanometre scale. However, the small length scales involved in nanomaterials present challenges in their characterisation, and in turn, their interaction with biological systems. The Advanced NanoBiomaterials Imaging Facility will provide state-of-the-art equipment for examining the properties of nan ....Advanced NanoBiomaterials Imaging Facility. The convergence of nanotechnology with biotechnology offers unprecedented opportunities to prepare nanomaterials with defined structure and function on the nanometre scale. However, the small length scales involved in nanomaterials present challenges in their characterisation, and in turn, their interaction with biological systems. The Advanced NanoBiomaterials Imaging Facility will provide state-of-the-art equipment for examining the properties of nanomaterials and their interaction with biosystems. The equipment will facilitate the development of new materials that are expected to underpin advances in drug delivery, diagnostics and implant devices, further strengthening Australia's strong reputation in these areas.Read moreRead less
Modulation of protein folding pathways: a new platform technology for molecular medicine. Misfolding of proteins is becoming recognised as a major cause of inherited disease. We propose to develop a chemical agent that will optimise the folding of alpha1-antitrypsin (AAT), misfolding of which gives rise to inheritable liver and lung disease. This agent will have potential application as a therapy for sufferers of AAT-misfolding disease and for improving the yield of AAT purified from human plasm ....Modulation of protein folding pathways: a new platform technology for molecular medicine. Misfolding of proteins is becoming recognised as a major cause of inherited disease. We propose to develop a chemical agent that will optimise the folding of alpha1-antitrypsin (AAT), misfolding of which gives rise to inheritable liver and lung disease. This agent will have potential application as a therapy for sufferers of AAT-misfolding disease and for improving the yield of AAT purified from human plasma, which is the current agent used to treat patients with AAT-misfolding disease.Read moreRead less
Drug particle characterisation. The understanding of drug particle characterizations is one of the key issues in the development of novel nasal sprayers for targeted drug delivery. A comprehensive study is proposed for characterising drug formation in sprayers and particle deposition in nasal cavity using the latest experimental and numerical techniques. A computer-aided design technology will be developed to optimise drug delivery systems. The new technology has great potentials leading to the ....Drug particle characterisation. The understanding of drug particle characterizations is one of the key issues in the development of novel nasal sprayers for targeted drug delivery. A comprehensive study is proposed for characterising drug formation in sprayers and particle deposition in nasal cavity using the latest experimental and numerical techniques. A computer-aided design technology will be developed to optimise drug delivery systems. The new technology has great potentials leading to therapeutic and economic benefits in developing advanced/innovative drug delivery systems and in evaluating the potential biological effects by the drugs to be introduced through the nose.Read moreRead less
OPTIMIZED NASAL DRUG DELIVERY SYSTEMS -- COMPUTER AIDED DESIGN. The aim of this project is to develop a computer-aided design technology to assist in targeted drug delivery through the human nasal cavity which is being recognised to be an excellent alternative route for the administration of medication drugs. The aim will be achieved by conducting computer modelling of nasal flow under realistic physiological conditions and by performing experimental measurements and testing to validate computer ....OPTIMIZED NASAL DRUG DELIVERY SYSTEMS -- COMPUTER AIDED DESIGN. The aim of this project is to develop a computer-aided design technology to assist in targeted drug delivery through the human nasal cavity which is being recognised to be an excellent alternative route for the administration of medication drugs. The aim will be achieved by conducting computer modelling of nasal flow under realistic physiological conditions and by performing experimental measurements and testing to validate computer models. The new technology has great potentials leading to therapeutic and economical benefits in developing advanced/innovative drug delivery systems and in evaluating the potential biological effects by the drugs to be introduced through the nose.Read moreRead less
Optimising vascularisation of tissue engineering chambers for construction of robust tissues. We have produced a device that has commercial application in several fields of basic science, biotechnology and bioengineering. When its full potential is achieved, our innovative organ chamber will strengthen Australia's standing in the biotechnology field and enrich specific applications. The knowledge gained from understanding the growth of blood vessels will benefit several fields including chemical ....Optimising vascularisation of tissue engineering chambers for construction of robust tissues. We have produced a device that has commercial application in several fields of basic science, biotechnology and bioengineering. When its full potential is achieved, our innovative organ chamber will strengthen Australia's standing in the biotechnology field and enrich specific applications. The knowledge gained from understanding the growth of blood vessels will benefit several fields including chemical bioengineering, tissue engineering and repair, polymer chemistry, therapeutics in many areas (like cancer, heart disease, diabetes), hormone manufacture for agricultural, veterinary and medical purposes and cosmetics manufacture. The project will train several post-doctoral fellows and PhD students in this cutting edge field of researchRead moreRead less
Discovery Early Career Researcher Award - Grant ID: DE120101302
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Lab-on-a-chip platforms for hemodynamics research: new approaches for the study of blood diseases. This project will use advanced microfluidic technologies to study how and why blood clotting occurs. New devices will be created that can precisely analyse the ability of blood to form clots and these will become powerful tools for the diagnosis of blood disorders and the research and validation of drugs for the treatment of these disorders.